Published in Liver Transpl on July 01, 2004
Liver cirrhosis. Lancet (2008) 6.11
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut (2007) 2.09
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Survival after liver transplantation in the United Kingdom and Ireland compared with the United States. Gut (2007) 1.51
Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B. Liver Transpl (2009) 1.46
HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice. PLoS Pathog (2009) 1.40
Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transpl (2011) 1.37
Management of acute liver failure. Nat Rev Gastroenterol Hepatol (2009) 1.32
Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet's nest! Gut (2006) 1.26
Current trends in living donor liver transplantation for primary sclerosing cholangitis. Transplantation (2011) 1.19
Primary sclerosing cholangitis. Can J Gastroenterol (2008) 1.17
Treatment of alcoholic liver disease. Dig Dis (2005) 1.10
Markov decision processes: a tool for sequential decision making under uncertainty. Med Decis Making (2009) 1.09
Update and actual trends on bacterial infections following liver transplantation. World J Gastroenterol (2008) 1.00
Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology (2009) 0.99
Using Bayesian networks to predict survival of liver transplant patients. AMIA Annu Symp Proc (2005) 0.98
The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis (2012) 0.97
Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) (2015) 0.96
Gender differences in liver donor quality are predictive of graft loss. Am J Transplant (2011) 0.96
Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol (2008) 0.94
Liver transplantation. Gut Liver (2009) 0.93
Hepatitis C virus-induced cytoplasmic organelles use the nuclear transport machinery to establish an environment conducive to virus replication. PLoS Pathog (2013) 0.88
A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis. J Gastroenterol (2009) 0.88
Liver transplantation for alcohol-related cirrhosis: a single centre long-term clinical and histological follow-up. Dig Dis Sci (2010) 0.87
Prevalence and risk factors for obesity after liver transplantation: a single-center experience. Hepat Mon (2013) 0.86
Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review. J Clin Transl Hepatol (2015) 0.86
Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013. Scand J Gastroenterol (2015) 0.86
Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med (2014) 0.85
Analyses of prognostic indices of chronic liver failure caused by hepatitis virus. World J Gastroenterol (2005) 0.85
Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure. J Gastroenterol (2012) 0.84
Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbecks Arch Surg (2014) 0.83
Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation. Microb Ecol (2012) 0.82
Joint Arthroplasties other than the Hip in Solid Organ Transplant Recipients. Open Orthop J (2009) 0.82
Liver transplantation for hepatitis C and alcoholic liver disease. J Transplant (2010) 0.81
Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner. Nat Clin Pract Gastroenterol Hepatol (2008) 0.81
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation. BMC Cancer (2011) 0.81
Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview. Autoimmune Dis (2012) 0.79
Tolerance and chimerism and allogeneic bone marrow/stem cell transplantation in liver transplantation. World J Gastroenterol (2013) 0.79
Assessment of nutritional status and health-related quality of life before and after liver transplantation. BMC Gastroenterol (2015) 0.79
Allocation of donor livers--is MELD enough? Liver Transpl (2004) 0.78
Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl (2011) 0.78
Ethnic disparities in liver transplantation. Gastroenterol Hepatol (N Y) (2011) 0.77
Care of the liver transplant patient. Can J Gastroenterol Hepatol (2014) 0.77
Effect of intestinal microbiota alteration on hepatic damage in rats with acute rejection after liver transplantation. Microb Ecol (2014) 0.76
Primary Sclerosing Cholangitis: Current and Future Management Strategies. Curr Hepat Rep (2013) 0.75
A single centre prospective study of liver function tests in post liver transplant patients. Indian J Clin Biochem (2012) 0.75
Time spent in hospital after liver transplantation: Effects of primary liver disease and comorbidity. World J Transplant (2016) 0.75
Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway. Int J Mol Sci (2016) 0.75
Factors Associated with Mortality and Graft Failure in Liver Transplants: A Hierarchical Approach. PLoS One (2015) 0.75
Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan. Medicine (Baltimore) (2016) 0.75
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV). Visc Med (2016) 0.75
Liver transplantation in Armed Forces-new kid on the block. Med J Armed Forces India (2012) 0.75
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
A randomized trial of protocol-based care for early septic shock. N Engl J Med (2014) 16.05
Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA (2002) 9.89
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
National estimates of severe sepsis in United States emergency departments. Crit Care Med (2007) 5.99
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65
Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med (2012) 5.22
Variation in critical care services across North America and Western Europe. Crit Care Med (2008) 5.00
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests. Circulation (2013) 4.46
The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med (2010) 4.41
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med (2008) 3.44
Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med (2012) 3.36
The epidemiology of mechanical ventilation use in the United States. Crit Care Med (2010) 3.28
Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med (2007) 3.27
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med (2003) 3.18
Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med (2007) 3.17
The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17
Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med (2006) 3.15
Pneumonia: still the old man's friend? Arch Intern Med (2003) 3.12
Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int (2002) 3.07
Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med (2002) 3.02
Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int (2009) 2.97
Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med (2009) 2.93
Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med (2015) 2.92
Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA (2010) 2.87
The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med (2006) 2.84
The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med (2012) 2.72
Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med (2013) 2.67
Critical care medicine training and certification for emergency physicians. Ann Emerg Med (2005) 2.67
End-of-life care for the critically ill: A national intensive care unit survey. Crit Care Med (2006) 2.61
Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med (2010) 2.50
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med (2003) 2.44
Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med (2013) 2.44
Prioritizing the organization and management of intensive care services in the United States: the PrOMIS Conference. Crit Care Med (2007) 2.42
Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity. J Palliat Med (2007) 2.39
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med (2008) 2.37
Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care (2010) 2.35
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med (2010) 2.31
Growth of intensive care unit resource use and its estimated cost in Medicare. Crit Care Med (2008) 2.31
Severe sepsis epidemiology: sampling, selection, and society. Crit Care (2004) 2.28
Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA (2010) 2.27
Perceptions of safety culture vary across the intensive care units of a single institution. Crit Care Med (2007) 2.24
Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA (2014) 2.23
Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int (2011) 2.22
A comprehensive career-success model for physician-scientists. Acad Med (2011) 2.20
Posttraumatic stress and complicated grief in family members of patients in the intensive care unit. J Gen Intern Med (2008) 2.12
Critical care medicine training and certification for emergency physicians. Crit Care Med (2005) 2.12
Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med (2005) 2.11
Severe sepsis and septic shock. N Engl J Med (2013) 2.10
A comparison of critical care research funding and the financial burden of critical illness in the United States. Crit Care Med (2012) 2.07
Do hospitals provide lower quality of care to black patients for pneumonia? Crit Care Med (2010) 2.07
Forging a critical alliance: Addressing the research needs of the United States critical illness and injury community. Crit Care Med (2009) 2.03
Exploring challenges and potentials of personal health records in diabetes self-management: implementation and initial assessment. Telemed J E Health (2007) 2.02
Use of intensive care services during terminal hospitalizations in England and the United States. Am J Respir Crit Care Med (2009) 2.00
Assessing the feasibility of the American College of Surgeons' benchmarks for the triage of trauma patients. Arch Surg (2011) 1.95
Critical care bed growth in the United States. A comparison of regional and national trends. Am J Respir Crit Care Med (2015) 1.93
How does lack of insurance affect use of intensive care? A population-based study. Crit Care Med (2006) 1.92
Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med (2008) 1.89
The first international consensus conference on continuous renal replacement therapy. Kidney Int (2002) 1.89
The effects of trauma center care, admission volume, and surgical volume on paralysis after traumatic spinal cord injury. Ann Surg (2009) 1.86
Using simulation to isolate physician variation in intensive care unit admission decision making for critically ill elders with end-stage cancer: a pilot feasibility study. Crit Care Med (2008) 1.81
Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume. Ann Intern Med (2007) 1.81
Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry (2005) 1.80
Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc (2007) 1.79
Physician attitudes toward regionalization of adult critical care: a national survey. Crit Care Med (2009) 1.79
An empirical study of surrogates' preferred level of control over value-laden life support decisions in intensive care units. Am J Respir Crit Care Med (2010) 1.79
Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med (2005) 1.77
Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med (2011) 1.77
Interest in the use of computerized patient portals: role of the provider-patient relationship. J Gen Intern Med (2008) 1.76
Variability in management of early severe sepsis. Emerg Med J (2010) 1.76
Racial variation in end-of-life intensive care use: a race or hospital effect? Health Serv Res (2006) 1.76
Quality of death: assessing the importance placed on end-of-life treatment in the intensive-care unit. Med Care (2004) 1.76
Identifying family members who may struggle in the role of surrogate decision maker. Crit Care Med (2012) 1.75
A randomized trial of the effect of patient race on physicians' intensive care unit and life-sustaining treatment decisions for an acutely unstable elder with end-stage cancer. Crit Care Med (2011) 1.75
Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial. Crit Care Med (2004) 1.73
Comparison of Cox and Gray's survival models in severe sepsis. Crit Care Med (2004) 1.72
Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med (2009) 1.71
Pregnancy and birth history influence women's experience of menopause. Menopause (2008) 1.71
Comparison of medical admissions to intensive care units in the United States and United Kingdom. Am J Respir Crit Care Med (2011) 1.69
The lingering consequences of sepsis: a hidden public health disaster? JAMA (2010) 1.67
Informal caregiver burden among survivors of prolonged mechanical ventilation. Am J Respir Crit Care Med (2006) 1.64
Access to urban acute care services in high- vs. middle-income countries: an analysis of seven cities. Intensive Care Med (2013) 1.64
Long-term outcomes from sepsis. Curr Infect Dis Rep (2007) 1.59
Development and validation of hospital "end-of-life" treatment intensity measures. Med Care (2009) 1.58
Reassessing the value of short-term mortality in sepsis: comparing conventional approaches to modeling. Crit Care Med (2003) 1.57
Accuracy of prehospital transport time estimation. Acad Emerg Med (2014) 1.56